Top Markets
#1 CoW Protocol CoW Protocol +59.73%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +39.17%
#4 Cysic Cysic +31.67%
#5 Walrus Walrus +25.40%
#6 Humanity Humanity +22.30%
#7 Enso Enso +17.07%
#8 Velvet Velvet +17.00%
#9 Tutorial Tutorial +16.94%
#10 Huma Finance Huma Finance +14.02%
Coin of the day
CoW Protocol CoW Protocol
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Relevium Technologies Inc. Relevium Technologies Inc.

Relevium Technologies Inc.

RLLVF
Rang in Aktien #37146
Relevium Technologies Inc. operates within the health and wellness sector,... Relevium Technologies Inc. operates within the health and wellness sector, focusing on identifying, assessing, acquiring, and managing various brands and businesses, primarily through e-commerce channels. The company distributes a range of products, including dietary supplements, nutraceuticals, sports nutrition items, and cosmeceuticals, mainly through its Bioganix online brand. It also offers dietary supplements under the LeefyLyfe label and skincare solutions marketed as the Push & Pull System. Additionally, Relevium has developed specialized lines such as Relevium Senior, aimed at older adults for inflammatory conditions affecting joints, heart, and brain, and Relevium Kids, providing nutraceuticals and oral nutritional supplements for children. Headquartered in Montreal, Canada, the company was formerly known as BIOflex Technologies Inc. until it rebranded to Relevium Technologies Inc. in December 2015.
Aktienkurs
$0.006
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$1.98M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Relevium Technologies Inc. (RLLVF)

Kategorie

Healthcare
P/B-Verhältnis für Relevium Technologies Inc. (RLLVF)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Relevium Technologies Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Relevium Technologies Inc. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.817 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0911 -
US